Skip to main content
Premium Trial:

Request an Annual Quote

Genomics England Taps WuXi Nextcode for Clinical Interpretation in Cancer, Rare Disease

NEW YORK (GenomeWeb) – Genomics England has contracted with WuXi Nextcode, a wholly owned subsidiary of WuXi AppTec, to provide clinical interpretations of genomics data from patients with cancer and rare disease as part of the UK's 100,000 Genomes Project.

NHS clinicians will use the company's database and its analysis and reporting infrastructure to identify causative variants in both rare disease and cancer cases. "We are delighted to be working with WuXi Nextcode," Augusto Rendon, director of bioinformatics at Genomics England, said in a statement. "Their sequence analysis platform will help us to return high-quality variant interpretation results back to clinicians and make a direct impact on patient care."

Hannes Smarason, president and COO of WuXi Nextcode, added "we look forward to putting our technology to work for NHS patients through interpretation and by applying the knowledge gained to advance the development of targeted new therapies for cancer and a range of rare conditions."

In September, Genomics England announced that it had signed contracts with Congenica and Omicia to interpret genomic data from the first 8,000 patients participating in the UK's 100K project. It also said at the time that it would keep working with Nanthealth and WuXiNextcode and also with reserve bidder Lockheed Martin, who is partnering with Cypher Genomics for the project.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.